These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 7809928

  • 1. Plasma thrombomodulin in orthotopic liver transplantation.
    Boutiere B, Arnoux D, Boffa MC, Samson D, Le Treut YP, Sampol J.
    Transplantation; 1994 Dec 27; 58(12):1352-5. PubMed ID: 7809928
    [Abstract] [Full Text] [Related]

  • 2. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
    Bellucci S, Ignatova E, Jaillet N, Boffa MC.
    Thromb Haemost; 1993 Nov 15; 70(5):736-42. PubMed ID: 8128427
    [Abstract] [Full Text] [Related]

  • 3. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM, Stephens CJ, Black MM, Hunt BJ.
    Clin Exp Dermatol; 1996 Jan 15; 21(1):28-32. PubMed ID: 8689765
    [Abstract] [Full Text] [Related]

  • 4. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR, Rosenfeld CS, Andrews DF, Nemunaitis J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN.
    Am J Hematol; 1996 Dec 15; 53(4):213-20. PubMed ID: 8948657
    [Abstract] [Full Text] [Related]

  • 5. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC, Stehouwer CD, van den Berg M, Vischer UM, Rauwerda JA, Emeis JJ.
    Thromb Haemost; 1997 Nov 15; 78(5):1332-7. PubMed ID: 9408014
    [Abstract] [Full Text] [Related]

  • 6. Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT).
    Himmelreich G, Dooijewaard G, Breinl P, Bechstein WO, Neuhaus P, Kluft C, Riess H.
    Thromb Haemost; 1993 Jan 11; 69(1):56-9. PubMed ID: 8446939
    [Abstract] [Full Text] [Related]

  • 7. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
    Rość D, Drewniak W, Kinasz-Rózycka I, Kulwas A, Michalski A.
    Pol Merkur Lekarski; 2003 Dec 11; 15(90):518-20. PubMed ID: 15058251
    [Abstract] [Full Text] [Related]

  • 8. The expression of von Willebrand factor, soluble thrombomodulin, and soluble p-selectin during orthotopic liver transplantation.
    Wang YI, Li G, Zhang Y, Gao W, Yao Z.
    Transplant Proc; 2007 Dec 11; 39(1):172-5. PubMed ID: 17275499
    [Abstract] [Full Text] [Related]

  • 9. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M, Mari D, Meroni PL, Gronda E, Vicari F, Frigerio M, Coppola R, Bottasso B, Borghi MO, Gregorini L.
    Br J Haematol; 2004 Jul 11; 126(1):85-92. PubMed ID: 15198737
    [Abstract] [Full Text] [Related]

  • 10. [Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus].
    Galajda P, Martinka E, Baláz D, Stasko J, Kerný J, Planková E, Mokán M, Kubisz P.
    Vnitr Lek; 1997 Nov 11; 43(11):744-7. PubMed ID: 9650506
    [Abstract] [Full Text] [Related]

  • 11. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP, Molenaar IQ, Verspaget HW, Veldman MG, Palareti G, Legnani C, Moolenburgh SE, Terpstra OT, Lamers CB, van Hoek B, Porte RJ.
    Thromb Haemost; 2004 Mar 11; 91(3):506-13. PubMed ID: 14983226
    [Abstract] [Full Text] [Related]

  • 12. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
    Salat C, Holler E, Kolb HJ, Pihusch R, Reinhardt B, Hiller E.
    Bone Marrow Transplant; 1997 May 11; 19(9):909-14. PubMed ID: 9156265
    [Abstract] [Full Text] [Related]

  • 13. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS, Wang C, Lu Y, Yang YH, Xing GH, Mao YL, Huang XX, Zhai ZG.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 20; 87(43):3074-8. PubMed ID: 18261355
    [Abstract] [Full Text] [Related]

  • 14. Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    de Moerloose P, Mermillod N, Amiral J, Reber G.
    Thromb Haemost; 1998 Mar 20; 79(3):554-6. PubMed ID: 9531039
    [Abstract] [Full Text] [Related]

  • 15. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
    Naumnik B, Pawlak K, Mys'liwiec M.
    Clin Appl Thromb Hemost; 2009 Feb 20; 15(1):84-91. PubMed ID: 17895513
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H, Kaneko T, Ohiwa M, Tanigawa M, Hayashi T, Tamaki S, Minami N, Deguchi K, Suzuki K, Nakano T.
    Am J Hematol; 1993 Oct 20; 44(2):101-5. PubMed ID: 8266913
    [Abstract] [Full Text] [Related]

  • 17. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E, Tousoulis D, Antoniades C, Katsi V, Bosinakou E, Vavuranakis E, Triantafyllou G, Marinou K, Tsioufis C, Papageorgiou N, Latsios G, Stefanadis C.
    Int J Cardiol; 2009 Apr 03; 133(2):266-8. PubMed ID: 18187214
    [Abstract] [Full Text] [Related]

  • 18. Altered endothelial function following the Fontan procedure.
    Binotto MA, Maeda NY, Lopes AA.
    Cardiol Young; 2008 Feb 03; 18(1):70-4. PubMed ID: 18093358
    [Abstract] [Full Text] [Related]

  • 19. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
    Karásek D, Vaverková H, Halenka M, Slavík L, Novotný D.
    Thromb Res; 2009 Feb 03; 123(3):466-75. PubMed ID: 18417194
    [Abstract] [Full Text] [Related]

  • 20. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years.
    Nilsson TK, Boman K, Jansson JH, Thøgersen AM, Berggren M, Broberg A, Granlund A.
    Thromb Res; 2005 Feb 03; 116(3):249-54. PubMed ID: 15935834
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.